Dermata Therapeutics Stock Analysis

Dermata Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.47. Some equities with similar Price to Book (P/B) outperform the market in the long run. Dermata Therapeutics recorded a loss per share of 13.36. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 16th of May 2024. Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company was incorporated in 2014 and is headquartered in San Diego, California. Dermata Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people. To learn more about Dermata Therapeutics call the company at 858 800 2543 or check out https://www.dermatarx.com.

Dermata Therapeutics Investment Alerts

Dermata Therapeutics Upcoming and Recent Events

Dermata Largest EPS Surprises

View All Earnings Estimates

Dermata Therapeutics Thematic Classifications

Dermata Stock Institutional Investors

Note, although Dermata Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Dermata Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.24 M.

Dermata Profitablity

Management Efficiency

Dermata Therapeutics has return on total asset (ROA) of (0.9068) % which means that it has lost $0.9068 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7301) %, meaning that it created substantial loss on money invested by shareholders. Dermata Therapeutics' management efficiency ratios could be used to measure how well Dermata Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of November 30, 2024, Return On Tangible Assets is expected to decline to -1.03. In addition to that, Return On Capital Employed is expected to decline to -1.33. At present, Dermata Therapeutics' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 5.53, whereas Total Assets are forecasted to decline to about 6.4 M.

Technical Drivers

As of the 30th of November, Dermata Therapeutics shows the Standard Deviation of 8.29, variance of 68.76, and Mean Deviation of 4.92. Dermata Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Dermata Therapeutics Price Movement Analysis

Dermata Therapeutics Insider Trading Activities

Dermata Therapeutics Outstanding Bonds

Dermata Therapeutics Predictive Daily Indicators

Dermata Therapeutics Forecast Models

Dermata Therapeutics' time-series forecasting models are one of many Dermata Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dermata Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Dermata Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Dermata shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Dermata Therapeutics. By using and applying Dermata Stock analysis, traders can create a robust methodology for identifying Dermata entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Dermata analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Dermata analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Dermata Therapeutics stock analysis indicators help investors evaluate how Dermata Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Dermata Therapeutics shares will generate the highest return on investment. By understating and applying Dermata Therapeutics stock analysis, traders can identify Dermata Therapeutics position entry and exit signals to maximize returns.

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.